DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells.

MLA

Seredinski, Sandra, et al. “DNA Topoisomerase Inhibition with the HIF Inhibitor Acriflavine Promotes Transcription of LncRNAs in Endothelial Cells.” Molecular Therapy. Nucleic Acids, vol. 27, Jan. 2022, pp. 1023–35. EBSCOhost, https://doi.org/10.1016/j.omtn.2022.01.016.

APA

Seredinski, S., Boos, F., Günther, S., Oo, J. A., Warwick, T., Izquierdo Ponce, J., Lillich, F. F., Proschak, E., Knapp, S., Gilsbach, R., Pflüger-Müller, B., Brandes, R. P., & Leisegang, M. S. (2022). DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells. Molecular Therapy. Nucleic Acids, 27, 1023–1035. https://doi.org/10.1016/j.omtn.2022.01.016

Chicago

Seredinski, Sandra, Frederike Boos, Stefan Günther, James A Oo, Timothy Warwick, Judit Izquierdo Ponce, Felix F Lillich, et al. 2022. “DNA Topoisomerase Inhibition with the HIF Inhibitor Acriflavine Promotes Transcription of LncRNAs in Endothelial Cells.” Molecular Therapy. Nucleic Acids 27 (January): 1023–35. doi:10.1016/j.omtn.2022.01.016.